Home > Boards > US Listed > Basic Materials > Danaher Corporation (DHR)

Danaher Corporation (Danaher) designs, manufactures and markets professional,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Penny Roger$ Member Profile
 
Followed By 1,052
Posts 280,404
Boards Moderated 10
Alias Born 03/18/11
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 5:25:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 5:24:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 5:23:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 5:19:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 5:18:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/29/2020 5:10:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:16:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:14:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:14:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:12:47 PM
Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance PR Newswire (US) - 7/23/2020 8:00:00 AM
Danaher 2Q Profit, Sales Rise Dow Jones News - 7/23/2020 6:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2020 6:25:04 AM
Danaher Reports Second Quarter 2020 Results PR Newswire (US) - 7/23/2020 6:00:00 AM
Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year PR Newswire (US) - 7/21/2020 4:52:00 PM
Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards PR Newswire (US) - 7/17/2020 9:15:00 AM
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs PR Newswire (US) - 7/16/2020 7:00:00 AM
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs PR Newswire (US) - 7/16/2020 7:00:00 AM
Danaher Schedules Second Quarter 2020 Earnings Conference Call PR Newswire (US) - 7/13/2020 4:15:00 PM
Fully Integrated SCIEX OS Software Launches at Virtual Product Experience Business Wire - 7/9/2020 11:00:00 AM
Danaher Unit's SARS-CoV-2 IgG Antibody Test Gets FDA Emergency Use OK Dow Jones News - 6/29/2020 8:46:00 AM
Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization PR Newswire (US) - 6/29/2020 8:00:00 AM
Beckman Coulter's SARS-CoV-2 IgG antibody test now available in markets accepting the CE Mark PR Newswire (US) - 6/15/2020 3:00:00 AM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/12/2020 4:25:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2020 7:31:49 AM
Penny Roger$   Thursday, 04/19/12 01:14:56 PM
Re: None
Post # of 76 
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company’s research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. In April 2011, the Company sold its Pacific Scientific Aerospace (PSA) business. On June 30, 2011, the Company acquired Beckman Coulter, Inc. (Beckman Coulter). In January 2012, the Company sold its Accu-Sort businesses. In February 2012, the Company sold its Kollmorgen Electro-Optical (KEO) business. During the year ended December 31, 2011, the Company acquired EskoArtwork, On February 6, 2012, L-3 Communications Holdings, Inc. acquired Kollmorgen Electro-Optical unit of the Company.

http://www.google.com/finance?q=DHR

My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist